Biocryst Pharmaceuticals Inc (BCRX) R&D Expenses & History | Stock Alarm

Demo Sign up Log In

Biocryst Pharmaceuticals Inc · R&D Expenses

BCRX R&D Expenses

Latest reported$197.76Mperiod endingJun 30, 2026

BCRX R&D Expenses ($0.00 → $197.76M)

Annual R&D Expenses

High-resolution chart · PNG

BCRX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	166,126,000
Dec 31, 2024	174,638,000
Dec 31, 2023	216,566,000
Dec 31, 2022	253,297,000
Dec 31, 2021	208,808,000
Dec 31, 2020	122,964,000
Dec 31, 2019	107,068,000
Dec 31, 2018	84,888,000
Dec 31, 2017	66,962,000
Dec 31, 2016	61,008,000
Dec 31, 2015	72,758,000
Dec 31, 2014	51,796,000
Dec 31, 2013	42,730,000
Dec 31, 2012	51,464,000
Dec 31, 2011	56,898,000
Dec 31, 2010	82,473,000
Dec 31, 2009	72,302,000
Dec 31, 2008	73,326,634
Dec 31, 2007	94,051,996
Dec 31, 2006	47,083,372
Dec 31, 2005	23,642,377
Dec 31, 2004	18,868,112
Dec 31, 2003	11,522,000
Dec 31, 2002	15,473,491
Dec 31, 2001	13,091,057
Dec 31, 2000	9,590,352
Dec 31, 1999	7,700,000
Dec 31, 1998	9,300,000
Dec 31, 1997	10,600,000
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.